| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.39T | 2.20T | 2.10T | 2.18T | 1.90T | 1.48T |
| Gross Profit | 737.74B | 688.04B | 603.02B | 584.52B | 563.85B | 434.32B |
| EBITDA | 443.22B | 396.95B | 343.36B | 364.01B | 337.67B | 251.82B |
| Net Income | 187.50B | 167.16B | 124.69B | 114.19B | 131.30B | 74.68B |
Balance Sheet | ||||||
| Total Assets | 4.34T | 3.54T | 3.42T | 3.15T | 3.04T | 2.36T |
| Cash, Cash Equivalents and Short-Term Investments | 878.16B | 697.31B | 650.00B | 506.19B | 439.34B | 380.39B |
| Total Debt | 754.64B | 608.40B | 685.74B | 752.16B | 679.81B | 525.68B |
| Total Liabilities | 2.23T | 1.73T | 1.70T | 1.68T | 1.74T | 1.40T |
| Stockholders Equity | 2.09T | 1.80T | 1.71T | 1.46T | 1.30T | 958.93B |
Cash Flow | ||||||
| Free Cash Flow | 169.22B | 220.55B | 228.42B | -12.94B | -112.35B | 18.66B |
| Operating Cash Flow | 430.02B | 445.84B | 447.01B | 262.77B | 178.99B | 230.85B |
| Investing Cash Flow | -337.66B | -244.84B | -216.59B | -234.40B | -281.66B | -237.37B |
| Financing Cash Flow | -51.73B | -143.33B | -146.37B | 14.95B | 113.86B | 27.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $411.76B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
74 Outperform | ¥6.47T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥35.10B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
67 Neutral | ¥3.88T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥1.03T | 15.16 | 8.05% | 1.58% | 0.96% | 3.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥493.06B | 15.62 | ― | 2.57% | 4.81% | -49.43% |